Grete Hogstad
Sales & Marketing at PHOTOCURE ASA
Net worth: 153 399 $ as of 2024-04-29
Network origin in Grete Hogstad first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Medical Specialties | 41 | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.
27
| Non-Profit Organization | Miscellaneous Commercial Services | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Grete Hogstad via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| MEDISTIM ASA | Medical Specialties | Director/Board Member Chief Executive Officer | |
| HIKMA PHARMACEUTICALS PLC | Pharmaceuticals: Generic | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Chairman Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Chairman | |
Radiumhospitalets Forskningsstiftelse
 Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway. | Financial Conglomerates | Chief Investment Officer Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Director/Board Member | |
| NEL ASA | Industrial Machinery | Chairman Director/Board Member | |
| Fairleigh Dickinson University | College/University | Director/Board Member Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree Doctorate Degree | |
| St. Francis College | College/University | Undergraduate Degree | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Chief Executive Officer | |
| ABLYNX | Biotechnology | Director/Board Member Chief Executive Officer | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| University of Oslo | College/University | Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Undergraduate Degree | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member Director/Board Member | |
| BI Norwegian Business School | College/University | Masters Business Admin Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
Acertys Group
 Acertys Group Medical SpecialtiesHealth Technology Acertys Group provides medical technology solutions. It provides high acute care, diagnostic care solutions, medical imaging, subacute consumables and accessories, and personal protective equipment. The company was founded in 2007 and is headquartered in Aartselaar, Belgium. | Medical Specialties | Chairman | |
ORCA Therapeutics BV
 ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
| IMPLANET SA | Medical Specialties | Director/Board Member | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Norge AS
 Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ULTIMOVACS ASA | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| CG ONCOLOGY, INC. | Biotechnology | President | |
Centre for Human Drug Research
 Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | Biotechnology | Director/Board Member | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| VISTIN PHARMA ASA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| OncoSTING LLC | Chairman | ||
Kaydence Pharma AS
 Kaydence Pharma AS Pharmaceuticals: MajorHealth Technology Kaydence Pharma AS engages in the manufacturing of pharmaceutical raw materials. The company was founded on October 27, 2017 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kaydence Pharma USA
 Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Kaydence Pharma USA operates as a pharmaceutical company. It offers vitamins, dietary supplement, and therapy to help patients prevent and reverse vascular diseases. The company is headquartered in East Brunswick, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistics
International
| Norway | 20 |
| United States | 19 |
| Netherlands | 5 |
| Denmark | 3 |
| Belgium | 3 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 11 |
| Finance | 2 |
| Producer Manufacturing | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 186 |
| Corporate Officer/Principal | 110 |
| Chairman | 61 |
| Chief Executive Officer | 61 |
| Independent Dir/Board Member | 49 |
Most connected contacts
| Insiders | |
|---|---|
| Jan Hendrik Egberts | 33 |
| Jon Hindar | 31 |
| Mats Gunnar Pettersson | 23 |
| Robert Stewart | 20 |
| Tom Edward Pike | 20 |
| Gwen Melincoff | 20 |
| Christopher Begley | 18 |
| Robert Grusky | 16 |
| Xavier Yon | 16 |
| Anne Hovi Worsøe | 16 |
| Hemanshu N. Pandya | 15 |
| Eva Steiness | 12 |
| Ingrid Beichmann Wiik | 12 |
| Anders Tuv | 12 |
| Peter Goldschmidt | 12 |
- Stock Market
- Insiders
- Grete Hogstad
- Company connections
